Gayle Smith, the Special Assistant to the President and Senior Director for Development and Democracy for the National Security Staff, participated last week in a live Twitter interview. Since there were so many great questions regarding development and aid, Gayle answered follow-up questions as well. Below, I have listed a few I found extremely interesting and pertinent to the global situation today!
Question: The way aid is given now, has any one studied it's value? Is there a better model?
Gayle Smith: There are many models of aid delivery but importantly, there are many more tools we are working to employ as we partner with countries to support sustainable development. We placed a premium on evidence-based lessons the world has learned as we were working with the President on his global development policy, in which aid is an important but not the only component of our development efforts. For example, we know there are many ingredients to creating conditions for countries’ sustainable growth.
It’s about encouraging entrepreneurship. Strengthening democratic institutions. Working to forge inclusive governments that reflect the diversity of their societies and are accountable to their people. We are partnering with countries to support such broad-based economic growth, which will be transformational in their own countries and critical to global prosperity and security far beyond their borders – including within our own.
Question: Why should the US fund vaccines used in the developing world? What proof do we have they're working?
Gayle Smith: We believe that vaccines are one of the most proven and cost-effective life saving investments for the world’s children, and that’s why we recently made tough choices and trade-offs within our current health portfolio to make a multi-year commitment to the Global Alliance for Vaccines and Immunizations (GAVI). Our investment was just one of many financial commitments – many of which were far larger than our own – so that our pledge was multiplied into billions of dollars in commitments, all to help get more vaccines to more children to protect them against pneumonia and diarrhea, the world’s two most potent childhood killers. In turn, all of these commitments combined have enabled vaccine manufacturers to announce major price reductions for new vaccines, so that more children will have access to these critical life-saving vaccines.
If you would like to hear more of Gayle Smith's answers go to: